Ipsen

Ipsen

Ipsen is a French pharmaceutical company headquartered in Paris, France. It primarily develops and markets medications used in oncology, endocrinology and the treatment of neuromuscular disorders. Wikipedia

Ipsen is a French pharmaceutical company headquartered in Paris, France. It primarily develops and markets medications used in oncology, endocrinology and the treatment of neuromuscular disorders. Wikipedia

May 11, 6:23 AM

Ipsen presents its new strategy and improved 2020 financial targets. http://www.ipsen.com/media/press-relases/ipsen-presents-new-strategy-improved-2020-financial-targets/

Mar 10, 8:10 AM

Honored to be nominated for the BD Boston Deal of the Year Award for our anticipated U.S. acquisition of Onivyde from Merrimack Pharmaceuticals. Proud to be recognized among such leading companies as @Allergan, @AstraZeneca, @Astellas, @Ganymed Pharmaceuticals, @Johnson & Johnson, @Bird Rock Bio, @Merck, @NewLink Genetics, @Takeda, @Ariad Pharmaceuticals, @Gilead Sciences & @Nimbus, who are seeking out innovative partnerships to help patients.

Jan 31, 9:56 AM

Ipsen to acquire Primary Care platform in Italy from Akkadeas Pharma http://www.ipsen.com/cp/media/press-releases/ipsen-acquire-primary-care-platform-italy-akkadeas-pharma/

Dec 21, 10:09 AM

Exelixis and Ipsen amend exclusive licensing agreement for the commercialization and development of cabozantinib to include Canada http://ipsen.to/zto7cta